EUVIMEDEUVIMED entdecken
Crossref

cGAS-mediated antibacterial immunotherapy against tuberculosis by macrophage-targeted manganese dioxide nanoagonist

Kangsheng Liao, Ruihong Chen, Jinwei Zhang, Yongdui Ruan, Xueqin Huang, Yuhe Huang, Jiaojiao Xia, Daina Zhao, Lingming Chen, Yi Zhao, Fen Yang, Jun-Fa Xu und 2 weitere

Acta Biomaterialia · 2025-04 · 196 · 471-486

DOI: 10.1016/j.actbio.2025.03.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Biomaterialia, 2025-04. Verfasst von Kangsheng Liao und 13 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, The First Dongguan Affiliated Hospital, School of Medical Technology, Guangdong…. Hauptthemen laut MEDLINE: Manganese Compounds, Macrophages, Immunotherapy, Mycobacterium tuberculosis. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: Guangdong Provincial Natural Science Foundation, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tuberculosis (TB), induced by Mycobacterium tuberculosis (Mtb) infection, remains one of the top killers among infectious diseases. The pathogenesis hallmarks for TB are complex immune escape mechanisms of Mtb and low targeting effects of anti-TB drugs. cGAS signaling, which is responsible for triggering host antibacterial immunity against Mtb infection, has shown potentials to serve as targets for anti-TB immunotherapy. As cGAS agonist manganese ions (Mn2+) can activate cGAS-mediated autophagy to inhibit intracellular Mtb in macrophages, we constructed a functional nanoagonist targeting cGAS signaling based on manganese dioxide nanoparticles, naming Tuf-Rif@HA-MnO2 NPs, for synergistic macrophage-targeted drug delivery and anti-TB immuno-therapeutics. Tuf-Rif@HA-MnO2 NPs can actively target macrophages for rifampicin delivery and react with intracellular glutathione (GSH) to release Mn2+ for cGAS-STING signaling activation, which further promote autophagy and antibacterial M1 polarization of Mtb infected macrophages to achieve synergistic intracellular Mtb clearance. Furthermore, Tuf-Rif@HA-MnO2 NPs can potentiate dendritic cell maturation, CD4+ Th1 cell and CD8+ cytotoxic T cell activation in vivo, which collectively attribute to reduced Mtb burdens and alleviated tissue inflammations in lung of Mtb-infected mice without systemic toxicity. This macrophage targeted drug delivery nanoagonist system is expected to develop rational immunotherapy strategy targeting cGAS signaling against TB and drug-resistant TB. STATEMENT OF SIGNIFICANCE: cGAS-mediated autophagy plays a critical role in Mtb clearance in macrophages. Tuf-Rif@HA-MnO2 NPs specifically deliver rifampicin into macrophage for Mtb clearance. Tuf-Rif@HA-MnO2 NPs activate cGAS-mediated macrophage autophagy for Mtb clearance. Tuf-Rif@HA-MnO2 NPs synergize cGAS-mediated immunotherapy with targeted drug delivery for more effective anti-TB treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Manganese CompoundsMacrophagesImmunotherapyMycobacterium tuberculosisNanoparticlesTuberculosisOxidesAnti-Bacterial AgentsAnimalsMiceRifampinMice, Inbred C57BLAutophagyRAW 264.7 CellsHumansFemaleNucleotidyltransferasesCyclic Guanosine Monophosphate-Adenosine Monophosphate Synthase

Stichwörter der Autor:innen

ImmunotherapyMacrophageManganese dioxide nanoparticlesTuberculosiscGAS/STING signaling

Substanzen

Manganese CompoundsOxidesRifampinAnti-Bacterial AgentsNucleotidyltransferasesmanganese dioxidecGAS protein, mouseCyclic Guanosine Monophosphate-Adenosine Monophosphate Synthase

Autor:innen und Institutionen

  • Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, The First Dongguan Affiliated Hospital, School of Medical Technology, Guangdong Medical University, Dongguan 523808, PR China; Research Center of Nan…
  • Department of Dermatology, Chongqing General Hospital, Chongqing 401147, PR China.
  • Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, The First Dongguan Affiliated Hospital, School of Medical Technology, Guangdong Medical University, Dongguan 523808, PR China.
  • Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Kunming Medical University, Kunming 650032, PR China.
  • Department of Microbiology and Immunology, University of Illinois at Chicago, Chicago, IL 60607, USA. Electronic address: lshen@uic.edu.

Förderung

  • Guangdong Provincial Natural Science Foundation
  • National Natural Science Foundation of China

Zitieren

APA

Liao, K., Chen, R., Zhang, J., Ruan, Y., Huang, X., Huang, Y., Xia, J., Zhao, D., Chen, L., Zhao, Y., Yang, F., Xu, J. F., Shen, L., & Pi, J. (2025). cGAS-mediated antibacterial immunotherapy against tuberculosis by macrophage-targeted manganese dioxide nanoagonist. Acta Biomaterialia, 196, 471-486. https://doi.org/10.1016/j.actbio.2025.03.002

Vancouver

Liao K, Chen R, Zhang J, Ruan Y, Huang X, Huang Y, et al. cGAS-mediated antibacterial immunotherapy against tuberculosis by macrophage-targeted manganese dioxide nanoagonist. Acta Biomaterialia. 2025;196:471-486. doi:10.1016/j.actbio.2025.03.002

BibTeX
@article{Liao2025,
  author = {Liao, Kangsheng and Chen, Ruihong and Zhang, Jinwei and Ruan, Yongdui and Huang, Xueqin and Huang, Yuhe and Xia, Jiaojiao and Zhao, Daina and Chen, Lingming and Zhao, Yi and Yang, Fen and Xu, Jun-Fa and Shen, Ling and Pi, Jiang},
  title = {cGAS-mediated antibacterial immunotherapy against tuberculosis by macrophage-targeted manganese dioxide nanoagonist},
  journal = {Acta Biomaterialia},
  year = {2025},
  volume = {196},
  pages = {471--486},
  doi = {10.1016/j.actbio.2025.03.002}
}
Kostenlos starten →